PCN127 COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN...

Value in Health 2019 / 05 Vol. 22

PCN127 COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB COMPARED WITH CURRENTLY AVAILABLE FIRST-LINE TREATMENTS IN PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC RENAL CELL CARCINOMA IN THE UNITED STATES

Tanova, N., Yang, S., Cheung, L.H., Genestier, V., Gooden, K.M., Malcolm, B., Rao, S., Choueiri, T.K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.251
Date:
May, 2019
File:
PDF, 322 KB
english, 2019
Conversion to is in progress
Conversion to is failed